期刊文献+

IL-6/sIL-6R复合物对血管内皮细胞VEGF及MMP-9表达的影响 被引量:7

IL-6/sI L-6R complex up-regulates VEGF and MMP-9 expression in human umbilical vein endothelial cells
下载PDF
导出
摘要 目的探讨IL-6/s IL-6R复合物对人脐静脉内皮细胞(HUVECs)血管内皮生成因子(VEGF)及基质金属蛋白酶-9(MMP-9)表达的影响。方法采用不同浓度的IL-6(0、10、20、40、80ng/ml)联合s IL-6R(100ng/ml)刺激HUVECs,培养24h后,分别采用real-time PCR及Western blot检测MMP-9、VEGF的m RNA及蛋白表达。结果在基因水平IL-6/s IL-6R复合物可诱导内皮细胞VEGF及MMP-9 m RNA的表达;在蛋白水平IL-6/s IL-6R复合物亦可促进VEGF及MMP-9的表达。结论 IL-6/s IL-6R复合物上调血管内皮细胞VEGF及MMP-9的表达,在类风湿关节炎(RA)的发病机制中起着重要的作用。 Objective To investigate the regulatory effect of IL-6/sIL-6R complex on expression of MMP-9 and VEGF in human umbilical vein endothelial cells (HUVECs). Methods Cultured HUVECs were treated with sIL-6R (100ng/ml) and various concentrations of IL-6 (0, 10, 20, 40 and 80ng/ml) for 24h, the expression of MMP-9 and VEGF was detected by real-time fluorescent quantitative PCR and Western blot. Results The mRNA and protein expressions of MMP-9 and VEGF were increased in presence of IL-6/sIL-6R complex (P〈0.05). Conclusion IL-6/sIL-6R complex can promote the expression of MMP-9 and VEGF in human umbilical vein endothelial cells, indicating that IL-6/sIL-6R complex may be involved in the pathogenesis of rheumatoid arthritis.
作者 蔺娜 宋欣伟 张缪佳 LIN Na;SONG Xinwei;ZHANG Miaojia(Department of Rheumatology and Immunologyt Zhejiang Provincial Hospital of Traditional Chinese Medicine, Hangzhou 310006, China)
出处 《浙江医学》 CAS 2018年第1期16-18,46,共4页 Zhejiang Medical Journal
  • 相关文献

参考文献2

二级参考文献44

  • 1王立丹,余成新.VEGF在类风湿关节炎血管生成中的作用及其研究进展[J].山东医药,2008,48(20):99-101. 被引量:11
  • 2王越,杨洁,高燕,牛文彦,姚智.卵巢癌细胞IL-6、IL-8及其受体表达的研究[J].免疫学杂志,2006,22(5):475-479. 被引量:16
  • 3Pflegerl P, Vesely P, Hantusch B, et al. Epidermal loss of JunB leads to a SLE phenolype due to hyper IL-6 signaling [J]. Proceedings of the National Academy of Sciences of the United States of America, 2009, 106(48): 20423-20428.
  • 4Knupfer H, Preiss sIL-6R: more than an agonist? [J]. Immunol Cell biol, 2008, 86(1): 87-91.
  • 5Heinrich PC, Behrmann I, Muller-Newen G, et al. Interleukin-6-type cytokine signalling through the gpl30/Jak/STAT pathway [J]. Biochem J, 1998, 334 ( Pt 2): 297-314.
  • 6Novotnydiermayr V, Lin B, Gu L, et al. Modulation of the interleukin-6 receptor subunit glycoprotein 130 complex and its signaling by LMO4 interaction [J]. The Journal of biological chemistry, 2005, 280(13): 12747-12757.
  • 7Frey N, Grange S, Woodworth T. Population Pharmacokinetic Analysis of Tocilizumab in Patients With Rheumatoid Arthritis [J]. J Clin Pharmacol, 2010, 50(7):754-766.
  • 8Jazayeri JA, Carroll GJ, Vernallis AB. Interleukin-6 subfamily cytokines and rheumatoid arthritis: role of antagonists [J]. Int Immunopharmacol, 10(1): 1-8.
  • 9Dayer JM, Choy E. Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor [J]. Rheumatology (Oxford, England), 2010, 49(1): 15-24.
  • 10Dienz O, Eaton SM, Bond JP, et al. The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4+ T cells [J]. J Exp Med, 2009, 206(1): 69-78.

共引文献82

同被引文献71

引证文献7

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部